Upstate Active Clinical Trials

Study Title:

A Phase III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPSCC

What is the purpose of the study? (in Layman's terms, please describe the study)

To find out whether it is more effective to take nivolumab immediately after chemoradiation, or active observation, and then be given nivolumab if your disease progresses.

Upstate Institutional Review Board (IRB) Number:

2037756

Study/Protocol ID:

EA3161

Study Phase:

3

Patient Age Group:

Adults

Principal Investigator:

Komal Akhtar

What is involved if I participate?

• How long is the study?
  10 years
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Chemotherapy, radiation, immunotherapy. For more information, please contact the CRA.

Where will the study take place?

The study takes place at the Downtown Cancer Center and some of the procedures can also be done at Community Hospital.

Other Information:

Please contact the CRA for more information.

ClinicalTrials.Gov ID:

NCT03811015

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Laine Abernathy
Phone: 315-464-6528
Email: [email protected]

Return to Previous Page || Search Again